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Treatment of rabbit 7S antibody with pepsin results in  the removal of an 
inactive fragment, leaving a bivalent residue with an average molecular weight 
of 106,000 and a  sedimentation coefficient of approximately 5S  (1, 2).  Subse- 
quent reduction of one labile disulfide bond splits this residual molecule into two 
univalent, non-precipitating fragments which migrate as a  single 3.5S peak (3) 
in the ultracentrifuge. These fragments closely resemble the univalent fractions 
of a papain digest (4) in a number of their properties. 
The  univalent  3.5S fragments obtained  by peptic  digestion  and  reduction  of  a 
specifically purified rabbit antibody can be recombined by oxidation,  in yields up to 
75 per cent, to give 5S antibody which again possesses precipitating activity (5). When 
a mixture of purified  rabbit antibodies of two different specificities is reduced and re- 
oxidized,  the  recombined  product  contains  a  considerable  amount  of  bivalent  5S 
"hybrid antibody"  (6,  7).  1 The recombination of fragments of  two different speci- 
ficities  appears to be essentially random,  as shown  by quantitative  analysis of the 
hapten-binding capacity of hybrid antiovalbumin-antibenzoate antibody before and 
after treatment with an adsorbent specific for the antiovalbumin (7). 
Previous  reports  from  these  and  other  laboratories  demonstrated  that  the  5S 
derivatives of several 7S rabbit antibodies retain most of the original  agglutinating 
activity on a molar basis (8, 9); the 3.5S derivatives lack agglutinating properties but 
combine with the homologous  antigen, as shown  by inhibition  of hemagglutination 
(9,  10)  or by a modified  antiglobulin reaction (8). 
The present  communication  extends  these  hemagglutination  studies  to  5S 
antibodies  obtained by reoxidation  of the  3.5S  univalent fragments.  The re- 
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t The phrase "hybrid antibody"  will be used to designate 5S antibody molecules of dual 
specificity; "hybrid  preparation"  denotes the  mixture of 5S antibodies formed in the pro- 
cedures described below. 
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suits indicate that a reconstituted 5S antibody can induce passive hem_agglutina- 
tion, and that reconstituted 5S hybrid antibody preparations produce passive 
mixed agglutination of two visually distinguishable red cell types, each coated 
with a  different antigen. With an artificial mixture of 5S antibodies (not hy- 
bridized), mixed agglutination does not occur; the two  cell types are aggluti- 
nated in separate homogeneous clumps. In the presence  of only one antigen, 
5S "hybrid preparations" produce significant agglutination only at concentra- 
tions much greater than those required for agglutination  of a  mixture of coated 
cells.  This  weak  agglutinating activity appears  related  to  the  monospecific 
bivalent 5S antibody, presumably formed in the reoxidafio~  stage in making 
the  hybrid  preparation.  However,  attachment  of  hybrid  antibody  to 
homologous antigens does occur at lower concentrations, as shown by a  modi- 
fied antiglobulin (Coombs') reaction and by stepwise agglutination  procedures. 
Materials and Methods 
Materia/s.--Bovine  gamma  globulin (BGG) and twice crystallized  chicken  ovalbumin 
(EA) were obtained from the Pentex Inc., Kankakee, Illinois; 2-mercaptoethylamine hydro- 
chloride (MEA) was purchased from the California Corporation for Biochemical Research, 
Los Angeles. 
Antisera.--Antisera  to EA or to BGG were prepared by intravenous inoculation of 2 to 3 
kg rabbits with 1 ml of a 1 per cent saline solution of the protein antigen three times weekly for 
6 weeks, followed by subsequent bleedings and inoculations at weekly intervals. Antisera of 
high titer obtained from a number of bleedings of several rabbits were pooled. The antibodies 
were specifically  purified by partial dissociation of a specific precipitate at pit 2.5 and frac- 
tionation at this pH with sodium sulfate (11). The 5S preparations were obtained from the 
purified antibodies by peptic digestion and precipitation with sodium sulfate (3). Amounts of 
antibody in precipitates were estimated as previously described (5). The percentages of protein 
in the antibody preparations precipitable by an optimal concentration of antigen were as fol- 
lows: anti-EA, 88 per cent; "5S" anti-EA, 85 per cent; anti-BGG, 76 percent; "5S" anti-BGG, 
61 per cent. The s,0,~ values of the purified anti-EA and anti-BGG were 6.5 and 6.9S, respec- 
tively; the value for each of the pepsin-treated antibodies was 4.6S. A slight amount of faster 
moving material (~ 10S) was present in the 6.5 and 6.9S preparations. 
Chicken antiserum to the 5S derivative of rabbit 7S gamma globulin (chicken anti-rabbit 
5S) was prepared by a similar immunization schedule. Before use, the chicken antiserum was 
absorbed with human erythrocytes. Aliquots were also absorbed with BGG for use in anti- 
globulin reactions with red cells coated with BGG; this was done to ensure that the chicken 
antiserum used in such reactions was actually reacting with the rabbit antibody and not by 
cross-reaction with the BGG. 
Measurements of Protein Coneentrations.--Protein concentrations were estimated by meas- 
urement of the absorbancy of solutions at 280 m#. The extinction coefficient  used for T-globu- 
lin is 1.50 optical density units per mg per ml; for 3.5 or 5S derivatives the corresponding  value 
is 1.48. 
Ultraventrifugal Analyses.--Sedimentation  velocities were measured in a 4°C, 12 mm cell 
in the Spinco model E ultracentrifuge at 59,780 RP~. The temperature  was maintained at 
20  ° 4- 0.2°C during each run. For correction of S values to s~0,~, the partial  specific volume 
was taken as that of untreated antibody. 
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anti-EA and anti-BGG by a  method similar to that described elsewhere (6). Thirty-five mg 
portions of each antibody preparation were mixed and treated with 1.4 mg of pepsin for 6 
hours at 37°C and pH 4.5. The major 5S product was separated by precipitation with sodium 
sulfate  (final concentration, 0.18 gm/ml), then reduced under nitrogen at pH 5.0 and 37°C 
for 90 minutes with 0.015 ~  mercaptoethylamine hydrochloride (MEA). The product had a 
sedimentation coefficient (s20.~) of 3.5S.  The reducing agent was removed by passage through 
a column of IR-120 cation-exchange resin at pH 4.5 in the cold room, and the 3.5S material 
was reoxidized by allowing the mixture to stand at neutral pH and room temperature. After a 
day, approximately 70 per cent had recombined to give a product with s~Q.w =  4.9S. The latter 
was  separated  from  the slower  sedimenting material by precipitation with sodium  sulfate 
(final concentration, 0.16 gm/ml). This product did not form precipitates when tested with a 
wide range of concentrations of either antigen. When 25/~g of ovalbumin and 40 #g of BGG 
were added as a  mixture to 800/zg of the product, 330 #g of precipitate formed. Because of 
lack of sufficient material a range of concentrations of the mixture of antigens was not tested. 
The failure to precipitate with a  single antigen, and the formation of precipitate with a mix- 
ture o1 antigens was reported previously (6), and is consistent with the presence of antibody 
of dual specificity in the product. 
Specifically purified antiovalbumin was treated with pepsin, reduced and reoxidized by an 
essentially identical procedure. The s20.w value of the product was 4.7S.  The fraction of the 
total protein precipitable by an optimal amount of ovalbumin was 55 per cent. The 5S anti- 
ovalbumin produced in this manner, by reoxidation of 3.5S fragments, could not be distin- 
guished serologically, either qualitatively or quantitatively, from the SS  material obtained 
directly by treatment with pepsin. 
Ery~hrocytes.--Human (type O, Rh-positive) and chicken whole bloods, obtained at weekly 
intervals, were mixed with equal volumes of Alsever's solution, and stored at 4°C. Prior to use 
in hemagglutination experiments, the erythrocytes were washed four times with 20- to 40- 
fold volumes of normal saline. 
Po.ssive Hemaggl~di~t~.--Antigens EA and BGG were coupled to human and chicken 
erythrocytes (rbc) respectively, by the chromic chloride method of Jandl (12). Prior to use, 
the BGG was absorbed with human and chicken erythrocytes to ensure the absence of hetero- 
antibody against these erythrocytes. In brief, 0.5 mi of a 50 per cent suspension of chicken rbc, 
1 ml of a  2.5 ~M solution of CrC18 and 2.5 ml of a  1 per cent BGG solution were mixed and 
allowed to stand at 20°C for 1 hour. Similar volumes of human cells, of 10 per cent EA, and 
of  15  ~  CrC13 were mixed  to provide EA-coated human red cells.  The concentrations of 
CrCl~ used were selected on the basis of Jandl's results (12). The concentrations of BGG and 
EA used were those which provided approximately maximal agglutination titers with specific 
antisera in preliminary tests. The "sensitized" erythrocytes were subsequently washed 6 times 
and suspended in saline. Two per cent suspensions of sensitized or non-sensitized (control) 
erythrocytes were used in agglutination reactions, which were carried out in l0 X  75 mm test 
tubes or on slides. In some experiments tannic acid (13)  rather than CrC13 was used to bind 
the antigens to the indicator erythrocytes. 
Serial dilutions, starting at 0.1 mg/ml, of purified anti-EA or anti-BGG, 5S anti-EA, 5S 
anti-BGG, or of "hybrid" 5S antibody preparations, were added to equal volumes of 2 per 
cent suspensions of coated or uncoated erythrocytes, and incubated for varying time intervals 
at room temperature. Dilutions were performed with separate pipettes to prevent carry over. 
The  mixtures were  studied  microscopically  (400-fold  magnification) for agglutination, and 
the degree of clumping graded as 0  to  ++++.  The cell types  (human, chicken, or both) 
present in the agglutinates were also ascertained, as were the types and approximate relative 
proportions of free  (non-agglutinated) cells in mixed cell populations. Specific  attention was 
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solely human ceils,  another solely chicken cells,  and a  third containing a  mixture of the two 
types of cells (mixed agglutinates). Comparative titers of different antibodies were determined 
by double blind readings of the mixtures of cells and antisera. 
"Two-step"  Agglutination  Procedures.--In  this procedure,  the  5S  "hybrid  preparation" 
was added to human cells coated only with EA (EA ceils). Mter incubation for 1 hour in 10 X 
75 mm test tubes at 20  ° or 37°C, the mixtures were centrifuged for 45 seconds in a Clay-Adams 
serofuge and read for agglutination. In the second step the ceils were thrice washed with 20- 
to 40-fold volumes of normal saline, and chicken antiserum prepared against the 5S derivative 
of rabbit gamma globulin (chicken anti-rabbit 5S) was added. The chicken antiserum, which 
contained approximately 60 #g antibody nitrogen per ml, was first diluted with 40 to  80 
volumes of saline. Similarly diluted normal chicken serum served as a  control. In some ex- 
periments the second step consisted of the addition of 0.1 ml of a  2 per cent suspension of 
chicken cells coated with BGG ("detector ceils") to the washed EA cells ("primary cells"). 
In either case, the mixture was kept at room temperature for 1 hour, then examined micro- 
scopicaily for mixed agglutination. 
Similar two-step experiments were performed by using BGG-coated cells as the primary 
ceil in the first step, and, as the second step, adding either chicken anti-rabbit 5S or EA-coated 
detector cells. 
Dispersal of Agglutinates  with Sulfhydryl  Reagent.--An  equal  volume  of  0.1  ~  MEA  in 
pH 7.2 buffered saline was added to the agglutinates obtained with various antibody prepara- 
tions (5S anti-EA, 5S anti-BGG, the hybrid preparation, or artificial mixtures of 5S anti-EA 
and 5S  anti-BGG). Agglutinates obtained with "7S"  anti-EA or  anti-BGG were  similarly 
treated.  The mixtures of antibody,  agglutinated cells,  and  MEA were  kept at  20°C  for 2 
hours. Buffered saline was substituted for MEA in simultaneous control experiments. If the 
agglutinates were dispersed by the MEA treatment, the cells were subsequently washed four 
times with isotonic saline, chicken antiserum to the 5S  rabbit gamma globulin was added, 
and the mixtures were read for agglutination. 
Dispersal of Agglutinates by Excess Antigen.--Reversai  of agglutination by  the addition 
of excess antigen was studied by the method of Lawler (14), as modified for mixed agglutinates 
by Milgrom et al. (15). Agglutinating mixtures were first allowed to stand for 1 hour at room 
temperature. The tubes were then centrifuged at 2000 m~ for 2 minutes and the supernatants 
were removed. The agglutinates were resuspended in 0.i ml of 1 per cent EA, of 1 per cent 
BGG, or of a  solution containing 1 per cent concentrations of both EA and BGG, and the 
resultant mixtures were  observed microscopically after incubation for 30 minutes at  room 
temperature. In other experiments, concentrations of antigen varying between 10.0 and 0.01 
mg/ml were used. In those suspensions in which dispersal did occur, the cells were tested for 
residual attachment of univalent antibody with chicken antiglobulin reagent. 
RESULTS 
Table  I  demonstrates  that coupling of antigens  EA  or BGG  to  human or 
chicken erythrocytes with CrC13 rendered the "coated" indicator cells agglufi- 
nable by the homologous, but not by the heterologous antibody. This was true 
whether a 7 or a 5S antibody preparation was used. 
The results in Table  II indicate  that, within the limits  of accuracy of  the 
doubling dilution method  employed  for  titration,  the specifically  purified  7S 
antibodies  or  their  5S  derivatives  possessed  equivalent  activity  on a  weight 
basis.  Reduced and reoxidized 5S anfiovalbumin also possessed  agglutinating H.  H.  !~UDENBERG, GENEVIEVE DREWS, AND A. NISONOF~"  1~5 
activity which,  by the doubling dilution method,  was equivalent  on a  weight 
basis to that of the 7S preparation from which it was derived. 
The  use  of  two  morphologically  distinct  erythrocyte  populations  (small 
round  human  ceils and  large,  oval,  nucleated  chicken  ceils) permitted facile 
TABLE I 
Passive Ilemagglutination Reaaions  of Spezifically Purified Antibodies to Ovalbumin (EA) and 
Bovine Gamma Globulin (BGG) with Homologous and I1eterologous Antigens 
Antigen* ...... 
Cells 
Antibody§ 
Anti-EA 
7S 
SS 
Anti-BGG 
7S 
SS 
Buffer control 
EA 
[H] 
+++ 
+++ 
BGG 
[Ch] 
+++ 
+++ 
0 
EA 
[Oh] 
+++ 
+++ 
BGG 
+++ 
+++ 
0 
None 
[HI 
None 
[Ch] 
* The antigen was attached to the specified cell type by the CrC13 method (see text). 
[H]  --- human cells; [Ch]  =  chicken cells. 
§ Antibody concentration: 0.1 mg/ml. 
TABLE  II 
Passive Agglutination  Reactions of Specif~ally  Purified  7 and 5S Anti-EA  or Anti-BGG  with 
Homologous Antigen* 
Anti-EA§ 
7S 
5S (pepsin-treated 7S) 
5S (reconstituted)[I 
Anti-BGG¶ 
7S 
5S (pepsin-treated 7S) 
++4- 
++4- 
++4- 
+++ 
+++ 
Log2 dilution of antibodyS 
++ 
++± 
++4- 
++4- 
++ 
+4- 
++4- 
++.4- 
++.4- 
++ 
+4- 
++4- 
++4- 
+ 
+ 
4  5  6 
+  4-  0 
+  4-  0 
+  4-  4- 
4-  0  0 
4-  0  0 
7  8 
m 
0 
0 
0 
I 
0 
0 
0  0 
0  0 
0  0 
0  0 
0  0 
* All antisera gave negative reactions with heterologous antigen at the initial dilution. 
:~ Initial concentration of antibody, 0.1 mg/ml. 
§ Human erythrocytes coated with EA were used for the agglutination tests. 
][ Reduced and reoxidized after pepsin treatment of 7S antibody. 
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differentiation of the two cell populations, and ready identification  of the  cell 
types present in each agglutinate. As is evident in Table III, line 5, addition of 
moderate concentrations of anti-EA to mixed suspensions of human cells coated 
with  EA,  [H]-EA,  and  uncoated  chicken cells,  [Ch],  produced homogeneous 
TABLE III 
Passive Mixed Agglutination Experiments* with 5S Derivatives of Specifically Purified A ntibodies 
Cells  and 
antigens used 
1.  [Chl 
2.  [HI 
3.  [Ch] +  [H] 
4.  [HI-EA 
5.  [HI-EA +  [Ch] 
6.  [ChI-BGG 
7.  [Ch]-BGG -F [H] 
8.  [Ch]-BGG + 
[H]-EA 
9.  [ChI-EA +  [HI-EA 
10.  [Ch]-BGG + 
[HI-BGG 
Anti-EA~ 
0 
0 
0 
+++ 
[H] only 
+++ 
[H] only 
0 
+++ 
[H] only 
+++ 
mixed 
[H] +  [Chl 
0 
Antibody  specificity (concentration, 0.01 mg/ml) 
Anti-BGG~ 
+++ 
[Ch] only 
+++ 
[Ch] only 
+++ 
[Ch] only 
+++ 
mixed 
[Ch] +  [H] 
Anti-EA and 
anti-BGG 
mixture 
0 
0 
0 
+++ 
[HI only 
+++ 
[H] only 
+++ 
[Ch] only 
+++ 
[Ch] only 
+++ 
some [HI only; 
some [Ch] only 
+++ 
mixed 
[HI +  [Ch] 
+++ 
mixed 
[HI q- [Chl 
Hybrid 
0 
0 
0 
0§ 
o§ 
orl 
0H 
+++ 
mixed 
[H] +  [Ch] 
0~ 
* [Ch] =  chicken cells; [HI =  human cells; [Chl-BGG =  BGG coupled to chicken cells; 
[H]-EA =  egg albumin  coupled to human cells; q-++  =  clumping; [HI q-  [Ch] =  both 
human and chicken cells within each clump. 
~t Similar results were obtained at concentrations  of 0.05 or 0.025 mg/ml. 
§ Rare clumps of 2 or 3 cells of [H] at concentrations of >0.05 mg/ml. 
I] Rare clumps of 2 or 3 cells of [Ch] at concentrations of >0.05 mg/ml. 
¶ Rare small clumps (2 to 4 cells) with only human or only chicken cells. 
agglutinates  composed  solely of human  cells;  non-agglutinated  chicken  cells 
were  readily  identified  in  the  suspension.  Comparable  results  were  obtained 
when chicken cells coated with BGG,  [Ch]-BGG, were substituted for the un- 
coated chicken cells (Table III, line 8). Again only human cells were seen in the 
agglutinates produced by the addition of EA (Fig.  1 a). 
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tions containing  [Ch]-BGG  produced agglutinates composed entirely of  large 
oval (chicken)  cells. The human cells in the mixture, either uncoated (line 7) or 
coated with EA (line 8) were not agglutinated by the anti-BGG.  The smaller 
human cells were randomly dispersed throughout the solution (Fig.  1 b).  Com- 
parable  results  (not listed)  were obtained when  the antigens  coupled to the 
human and chicken  cells were reversed; i.e., with [Ch]-EA and [H]-BGG.  Be- 
cause of occasional  difficulty in coupling BGG to human cells, the majority of 
subsequent titration experiments were performed with [Ch]-BGG  and  [H]-EA. 
When artificial  mixtures of 5S anti-EA and 5S anti-BGG  (not hybridized) 
were added to a mixed suspension  of [Ch]-BGG and [H]-EA, two distinct types 
of agglutinates were produced, one containing only human cells, the other only 
chicken cells (Table III, line 8; Fig.  1 c). In contrast, addition of the  "hybrid 
TABLE  IV 
Inhibition  by Soluble Protein Antigens  of Passive Hemagglutination Caused by 5S Antibodies* 
Antibody 
Anti-EA 
Anti-BGG 
Hybid 
BUffer 
Cells 
[H]-EA 
[Ch]-BGG 
[HI-EA +  [Ch]-BGG 
[HI-EA +  [Ch]-BGG 
Inhibitor  (I  mg/ml) 
Buffer 
+++ 
o 
EA 
o 
+o++ 
o 
BGG 
+o++ 
o 
o 
EA + 
BGG 
* Antibody concentration: 0.02  mg/ml. 
preparation"  to similar  cell mixtures produced  distinctive mixed agglutinates 
with multiple large clumps,  all containing both human and chicken cells  (Table 
III, line 8; Fig. 1 d). Large mixed agglutinates were observed throughout the 
suspension.  Single non-agglutinated cells or small homologous clumps consisting 
of fewer than 5 cells of a single species were seen only occasionally. 
All the experiments in Table III were repeated with cells coated with antigen 
by the use of tannic acid rather  than chromic chloride.  The results obtained 
were identical with those described above. 
The  dual specificity of the hybrid was demonstrated by inhibition  experi- 
ments (Tables IV and V) in which cells coated by the chromic chloride  and by 
the tannic acid methods were used. (It should be noted that the hybrid prepara- 
tion  presumably contained,  in  addition  to  the  antibody of dual  specificity, 
monospecific  bivalent anti-EA  and  monospecific  bivalent anti-BGG.)  Either 
antigen (EA or BGG) inhibited the agglutination produced by addition of the 
5S hybrid preparation to a mixture of the two types of coated cells (Table IV, 
line 3). Quantitative inhibition data are given in Table V. 
In contrast, agglutination of [H]-EA by 5S anti-EA, or of [Ch]-BGG  by 5S 
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(Table IV, lines 1 and 2; Table V). The concentration of antigen necessary for 
complete inhibition was less than 0.02 mg/ml in each case (Table V). 
High concentrations of the hybrid preparation agglutinated a cell suspension 
containing one cell type coated with antigen and uncoated cells of the other 
type (Table VI, rows 1 and 2). However, titers were 8 to 16 times greater when 
a mixture of cells coated with each of the antigens was used (Table VI, row 3). 
The agglutination of a single coated cell type is consistent with the presence in a 
hybrid preparation of monospecific bivalent antibody. The considerably greater 
titers observed with a mixture of coated cell types is in accord with the morpho- 
TABLE V 
Inhibitory Effects of Antigens on Passive Hemagglutination  Caused by 5S Specifically Purified 
Antibodies* 
Concentration of 
EA or BGG 
mg/ml 
2.0 
0.4 
0.02 
0.004 
O.0008 
Buffer 
5S Anti-EA+ 
[H]-EA$ 
~Iomo- 
logous 
antigen 
Hetero, 
logou~ 
antigex 
++ 
++ 
++ 
++ 
++ 
++ 
5S Anti-BGG + 
[Ch] -- BGG~; 
Homo-  Hetero- 
logous  logous 
antigen  antigen 
o  + 
o  + 
o  + 
o  + 
+  + 
+ 
Hybrid +  [H]--EA +  [Ch]--BGG 
EA  BGG  Both 
o  o  0 
0  0  0 
+0±  0  o 
+o+  +± 
++  ++ 
++ 
* The antibody concentration in each experiment was 0.01 mg/ml. 
:~ The symbols [H] and [Ch] refer to human and chicken erythrocytes, respectively. 
logic evidence (mixed agglutination), for the presence of antibody of dual spe- 
cificity. 
The relatively low titer of the hybrid preparation against a single coated cell 
type was increased by the anfiglobulin reaction to a level nearly as great as that 
observed in direct agglutination experiments utilizing both cell types (Table 
VI, rows 4 to 6). The antiglobulin reaction did not enhance the titer of the hy- 
brid preparation against a  mixture of cell types (rows 3 and 6), nor did it en- 
hance the titer of 5S anti-EA against [H]-EA (rows 7 and 10).  The enhance- 
ment, by the antiglobulin reaction, of the titer of the hybrid preparation against 
a single cell type is consistent with the attachment to red cells of hybrid mole- 
cules which are effectively univalent in the presence of a  single antigen. The 
agglutinates formed in this case contained only the cell type coated with anti- 
gen. The univalent 3.5S fragments of anti-EA did not cause direct agglutina- 
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TABLE  VI 
Titus o(.purified  Antibody  against Cells Coated with One or with Both Antigens 
Antibody 
Hybrid 
Agglutina- 
tion 
Antiglobu- 
lin~ 
5S anti-EAll 
Agglutina- 
tion 
Antiglobulin 
3.5S anti-EA 
Agglutina- 
tion 
Antiglobulin 
Cell type and  Row 
antigen  No. 
Log2 dilution of antibody* 
1  2  3  4  5  6  7  Buffer 
[H]-EA +  [Ch]  1  +++  +4-  +  0  0  0  0  0  0 
[Ch]-BGG+ [HI  2  +++  +  0  0  0  0  0  0  0 
[H]-EA+[Ch]-  3  +++4-+++++++4-  +  +i  4-  0  0 
BGG 
[HI-EA +  [Chl  4  X § 
' [Ch]-BGG +  [H]  5  X 
[H]-EA +  [Ch]-  6  X 
BGG 
X  X  +4-  +  +'0  '0  0 
X  +4-  +4- +4-  4-  0  0  0 
X  X  X  X  X  X  0  0 
[H]-EA  7  ++-4-  ++4-  ++  ++  +  4-'0  0  0 
[Ch]-BGG  8  0  0  0  0  0  0  0  0  0 
[H]-EA+[Ch]-  9  ++-4-  +4-  +  4-  4-  0  0  0  0 
BGG 
[H]-EA  10  X  X  X  X  X  X  0  0  0 
[Ch]-BGG  11  0  0  0  0  0  0  0  O  0 
[H]-EA+[Ch]-  12  X  X  X  X  X  0  0  0  0 
BGG 
[HI-EA  13  0  0 
[Ch]-BGG  14  0  0 
[H]-EA +  [Ch]-  15  0  0 
BGG 
0  0  0  0  0  0  0 
0  0  0  0  0  C  0 
0  0  0  0  0  O  0 
[H]-EA  16  +-4-+  ++  ++  +-4-  +  -4-'  0  0  0 
[Ch]-BGG  17  0  0  0  0  0  0  0  0  0 
[H]-EAW[Ch]-  18  +++  ++  ++  -¢-  -¢-  0  0  0  0 
BGG 
* Initial concentration 0.1 mg/ml. 
Equal volume (0.1 ml) of 1:10 dilution of chicken anti-rabbit 5S serum added to thrice 
washed cells. 
§ X, agglutination in saline prior to addition of antiglobulin reagent. 
]1 This 5S anti-EA was obtained by reoxidation of 3.5S anti-EA (see text). 
observed with the homologous antigen (rows 16 and 18). The activity was ap- 
proximately equal on a  weight basis to that of the hybrid preparation in an 
antiglobulin test with cells coated with EA (rows 4 and 6). 
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gen was also demonstrable by a  stepwise agglutination procedure which pro- 
duced typical mixed agglutinates (Table VII). In this procedure (see Materials 
and Methods) the cells coated with one antigen were exposed to hybrid anti- 
body (0.02 mg/ml) and washed; coated detector cells of the second type were 
then added. In each case agglutination resulted. 
When 3.5S monospecific antibody rather than hybrid antibody was used to 
TABLE VII 
Stepwise Agglutination Method* 
Antibody 
Hybrid 
3.5S anti-EA 
Primary  cell 
and "coat" 
[H]-EA 
[Ch]-EA 
[H]-BGG 
[Ch]-BGG 
[HI-EA 
[Chl-EA 
[HI-BGG 
[Chl-BGG 
[H]-EA 
+++~ 
[HI 
+++§ 
[HI [Ch] 
Detector cell and "coat" 
[Ch]-~A  [HJ-BGG 
o  +++~ 
[H] 
o  +++§ 
[HI [Chl 
+++§  0 
[H] [Ch] 
+++~  o 
[Ch] 
0  0 
0  0 
0  0 
0  0 
[Ch]-BGG 
+++§ 
[HI [Ch] 
+++~ 
[Chl 
0 
[H]  [Ch] 
0  0 
o  o 
o  0 
o  0 
0  0 
0  0 
0  0 
0  0 
* Antibody, 0.02 mg/ml, was incubated with an equal volume of coated primary cells for 
1 hour at 20°C; cells were then washed three times and detector ceils added. 
:~ Homologous agglutinates; cells of only one species. 
§ Mixed agglutinates; cells of both species. 
coat the "primary cell," addition of the "detector cell" failed to produce agglu- 
tination (Table VII). 
In another group of experiments (not tabulated) it was found that incubation 
of the hybrid preparation with soluble homologous antigen (1 mg/ml), prior to 
exposure to the primary cell, prevented attachment to the cells, as evidenced 
by failure of agglutination upon subsequent addition of detector cells; prior 
incubation with heterologous antigen had no such inhibitory effect. 
The agglutination induced by the hybrid antibody in mixed cell suspensions 
of [H]-EA and [Ch]-BGG was reversed by the addition of 0.1 M mercaptoethyl- 
amine  (MEA)  (Table  VIII,  line  2).  (This  concentration of  reducing  agent 
rapidly splits the 5S molecule into two univalent fragments, reference 1.) How- 
ever, the fragments thus produced remained attached to antigens on the dis- 
persed  cells.  This  was  demonstrated by  the  subsequent  use  of  the  chicken H.  H.  IUDENBERG,  GENEVIEVE  DREWS,  AND  A.  NISONOFF  161 
anti-rabbit 5S reagent. Its addition produced strong agglutination. Each clump 
contained both human and chicken cells. MEA also dispersed the agglutinates 
obtained when mixtures of 5S anti-EA and 5S anti-BGG (not hybridized) were 
added  to mixed [Ch]-BGG and  [H]-EA suspensions.  Subsequent  addition  of 
antiglobulin resulted in mixed  (heterogeneous)  clumps  (Table VIII, line  2). 
TABLE VIII 
Effects of Sequential Addition  of Dispersing Agent and Antiglobulin Reagent on Agglutinates 
Induced by Various 5S Antibodies 
Symbols in the table show all types in the agglutinates observed after each procedure. 
I  Mixture of 5S  Antibody* ...........  anti-BGG  +  5S anti-EA  5S anti-BGG 
I 
i  tt~kl 
Antigen ....  [Cb]-BGG+tH]-EA  B d~iI-II  _.. 
m 
Test method ......  i..I  A* 
l 
Dispersing Agent 
1. None  (buffer 
control) 
i  2. MEA$:~ 
3.  1 per cent EA H- 
BGG 
4.  1 per cent EA 
5.  1 pe  r cent BGG 
[HI + 
o[Ch]ll 
o 
[Ch] 
[HI 
B§  At 
¶  [Ch] 
[Chl-[Hl**  0 
0  0 
¶  [Chl 
¶  0 
B§ 
¶ 
[Chl 
0 
5S anti-EA 
A~  B§ 
[HI  ¶ 
o  [H] 
0  0 
0  0 
[HI ~  ¶ 
5S hybrid 
[Cbl-B~iHI'EA 
A~  13§ 
[Chl-[H]**  ¶ 
0  [Chl-iH]*' 
0  0 
o  [Chl 
o  [HI 
* 0.01 rag/m1. 
Antibodies, coated cells, and dispersing agent mixed together and examined after 1 hour 
for agglutination. Table shows types of agglutinates observed. 
§ Antiglobttlin test. (Chicken anti-rabbit 5S serum added to thrice washed cells after pro- 
cedure A.) 
I1 Separate homologous  dumps of only chicken or only human ceUs. 
¶ Agglutinates present prior to addition of antiglobulin reagent. 
** Mixed agglutinates. Each clump contains both chicken [Ch] and human [H] cells. 
;~: 0.1 g Mercaptoethylamine (see text for condition of use). 
Agglutinates produced by mixing 5S anti-BGG and [Ch]-BGG in the presence 
of uncoated human cells were similarly dispersed by MEA.  Subsequent addi- 
tion of antiglobulin reagent resulted in the formation of clumps containing only 
chicken cells.  When agglutinates  made with  [H]-EA and 5S anti-EA, in  the 
presence of uncoated chicken cells, were dispersed with MEA, subsequent addi- 
tion of chicken anti-rabbit 5S reagent resulted in clumps containing only human 
cells.  The fact that MEA caused dispersal of each type of agglutinate is con- 
sistent with previous demonstrations that it cleaves the bivalent 5S molecules 
produced by pepsin,  or by reoxidation of reduced 5S protein, into univalent 
fragments. The composition of the agglutinates formed in each instance after 162  SEROLOGIC  DEMONSTRATION  OF  DUAL  SPECIFICITY 
the addition of antiglobulin reagent indicates  that  the univalent fragments 
liberated by MEA remained in combination with homologous antigen on the 
cells. 
In other experiments (not tabulated) it was observed that addition of MEA 
did not result in dispersal of agglutinates made with 7S anti-EA and [H]-EA or 
with 7S anti-BGG and [Ch]-BGG. 
Agglutinates induced by monospecific 5S anti-EA or 5S anti-BGG were also 
dispersed by addition of a solution of homologous antigen (Table VIII, lines 3 to 
5).  The results differed, however, from those obtained with MEA in that the 
dispersed cells did not agglutinate following addition of the anfiglobulin serum. 
Thus the addition of excess soluble  antigen, in contrast to MEA, evidently 
caused detachment of antibody. 
Addition  of  either  EA  or  BGG  to  the  mixed  agglutinates  of  [H]-EA 
and [Ch]-BGG induced by the hybrid was sufficient to cause dispersal  (Table 
VIII). However, when only EA was added to the agglutinates, attachment of 
antibodies to cells coated with BGG persisted, as was demonstrable by the anti- 
globulin reaction. Similarly, addition of BGG to the same type of agglutinate 
resulted in dispersal, but antibody remained bound to cells coated with EA, as 
shown by the antiglobulin test. Presumably the antibodies included both the 
hybrid and monospecific bivalent antibody in the hybridized mixture, the latter 
in amounts insufficient to cause agglutination. Addition of both antigens to the 
agglutinates produced by the hybrid caused dispersal  without demonstrable 
attachment; the antiglobulin reaction in this instance was negative (Table VIII, 
line 3). 
DISCUSSION 
The  results  of these investigations demonstrate  the  applicability  of  the 
mixed agglutination technique to the study of the properties of rabbit antibody 
of dual  specificity  (hybrid antibody).  Previous reports  (6,  7)  have demon- 
strated the formation of hybrid antibodies following reduction and reoxidafion 
of a mixture of two specifically purified, pepsin-treated antibodies of differing 
specificities. The present experiments provide a  direct, visual confirmation of 
the mixed specificity of these molecules. 
The mixed agglutination technique was first employed by Topley et al. with 
a mixture of 2 serologically unrelated and morphologically distinct bacterial 
species (16). Microscopic examination of the agglutinates induced by addition 
of a mixture of the 2 corresponding antiserums invariably revealed homologous 
agglutinates consisting solely of separate clumps of each bacterial species. Re- 
cent extensions of the mixed agglutination technique by Coombs and coworkers 
(17, 18) have demonstrated the unique applicability of such reactions for study 
of antigens on cell surfaces.  The elegant experiments of Milgrom a  a/.  (15) 
demonstrated that inert indicator erythrocytes of two morphologically distinct H.  H.  ~'UDENBERG,  GENEVIEVE  DR.EWS~ AND  A.  NISONO~'F  16,] 
species  (human and alligator), coated in vitro with differing  test antigens, can 
be readily utilized in mixed agglutination experiments for studies of specificity 
of rheumatoid serums and for the detection of molecules in such serums capable 
of reacting with two different antigens  (human  and rabbit ganuna globulin). 
Jacot-Guillarmod and Isliker (19) have recently utilized mixed agglutination to 
demonstrate in vitro formation of antibody of mixed specificity by reduction and 
reoxidation of a mixture of anti-A and anti-B isoagglutinins  of high molecular 
weight. 
The mixed agglutination experiments reported here were carried out with 5S 
hybrid obtained by oxidation of a  mixture of 3.5S fragments of anti-EA and 
anti-BGG. Such hybrid antibody was consistently found to yield mixed aggluti- 
nates of chicken and human erythrocytes when each cell type had been coated 
with one of the two homologous antigens, EA or BGG. In contrast, an artificial 
mixture of 5S anti-EA and 5S anti-BGG  (not hybridized) produced separate 
clumps, each containing only a single type of erythrocyte. 
The hybrid antibody also caused agglutination of a single species of erythro- 
cyte, coated with a single antigen, but at a significantly  lower titer than  was 
observed with the mixture of coated erythrocytes. The agglutination of a single 
cell  type is consistent with the presence of some bivalent antibody of single 
specificity in  the  hybridized  mixture  (7).  For  random  association  of  equal 
amounts of fragments of specificities A and B, one would expect to obtain anti- 
bodies A-A, B-B, and A-B in the ratio 1:1: 2. The A-A or B-B could well be re- 
sponsible for the agglutination  of a  single,  coated cell type. The species  A-B 
should act as an effectively univalent antibody in an experiment with a single 
type of ceil, and tend to inhibit agglutination. Apparently the amount present 
was insufficient  to cause complete inhibition.  A few experiments were carried 
out to test the inhibitory capacity of 3.5S (univalent) fragments of anti-EA; the 
minimum  weight ratio  of 3.5S anti-EA  to 5S anti-EA  required for complete 
inhibition of agglutination of [I-I]-EA was approximately 20 to 1. This high ratio 
is probably attributable to the presence of a large excess of antigenic sites on the 
coated cells, as compared with the amounts of antibody required for agglutina- 
tion; it is consistent with the observation that a hybrid preparation is capable 
of agglutinating a single coated cell type. 
The fact that agglutination of a mixture of coated cells by the hybrid anti- 
body was prevented by an excess of either antigen (Table V) is consistent with 
a mechanism of agglutination in which the red ceils having different antigenic 
coats are linked by molecules of mixed specificity. 
Similarly,  the mixed agglutinates formed by hybrid antibody could be dis- 
persed by addition of either  antigen  (Table VIII).  However, antibody com- 
bining sites of the other specificity remained in combination with erythrocytes 
having the corresponding antigenic coat, as shown by subsequent antiglobulin 
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used for dispersal was agglutinated upon addition of the chicken anti-5S  anti- 
serum. 
The results  of stepwise agglutination tests were consistent with the attach- 
ment of the hybrid antibody to a single coated cell type (Table  VII). When 
such antibody was used in an amount insufficient to cause agglutination, sub- 
sequent addition of cells coated with the second antigen resulted in agglutina- 
tion. Individual clumps in this case contained both cell types. The titer of hybrid 
antibody for mixed agglutination by the stepwise procedure was found in sepa- 
rate experiments  to be approximately the same as that for agglutination by 
addition to a mixture of coated ceils. 
The fact that each type of agglutinate could be dispersed by treatment with 
0.1 ~ mercaptoethylamine is consistent with the chemical nature of the 5S anti- 
body. In this molecule two univalent fragments are linked by a labile disulfide 
bond. Evidently the reducing agent cleaves the bond and thereby destroys the 
lattice in which the red cells are linked. However, the univalent fragments re- 
main attached to the antigens coating the erythrocytes; on subsequent addition 
of antiglobulin reagent,  agglutinates are again formed. When both coated cell 
types and a mixture of the two monospecific 5S antibodies  were used for  the 
first agglutination, separate homologous clumps  formed.  However,  after  dis- 
persal with MEA and reagglutination with the chicken anti-rabbit 5S,  mixed 
clumps were observed, as would be expected since chicken anti-SS reacts with 
each of the rabbit 5S antibodies. 
Evidence suggesting the presence in ~ivo of multivalent antibodies with dual 
specificity against blood group A and B antigens in group O sera has been ob- 
tained by Dodd (20). Other possible interpretations of Dodd's data have been 
proposed and are discussed in detail by Kabat (21). The molecular size of these 
antibodies was not determined, but if they are indeed multivalent it would seem 
unlikely that they are 7S since the 7S antibodies of several other species have 
been found to be bivalent. Milgrom et al. (15) have described rheumatoid factors 
(macroglobulins) of mixed specificity directed against rabbit and human gamma 
globulins but these results are probably entirely explainable on the basis of anti- 
genic determinants common to both rabbit and human gamma globulin. How- 
ever, attempts to demonstrate the presence of 7S antibody of dual specificity in 
rabbits hyperimmunized with two antigens have been uniformly unsuccessful 
(22-27). Experiments of the types reported here should be useful as a model for 
determining whether very small amounts of hybrid 7S molecules are iormed in 
~o. 
SUMMARY 
Hybrid,  bivalent antibody molecules  bearing  specific combining  sites  for 
both ovalbumin and bovine gamma globulin were produced by reoxidation of a 
mixture of the 3.5S fragments of the two specifically purified antibodies.  The H. H. I~UDENBER%  GENEVIEVE  DREWS,  AND A. NISONO~'F  165 
dual specificity and the properties of the hybrid antibody were demonstrated 
by mixed agglutination and two stage agglutination experiments, and by test 
systems utilizing inhibition of agglutination or dispersal  of  agglutinates fol- 
lowed by antiglobulin reactions. 
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EXPLANATION OF PLATE 5 
FIGS. 1 a to 1 d. Agglutinates  made with [Ch]-BGG, [H]-EA, and the following 5S 
antibodies:  1 a,  anti-EA;  1 b,  anfi-BGG; 1 c, mixture of anti-EA and anfi-BGG; 
1 d, hybrid preparation of anfi-EA and anti-BGG.  )< 381. THE JOURNAL  OF EXPERIMENTAL MEDICINE  VOL.  119  PLA'IE 5 
(Fudenberg et al.:  Serologic demonstration of dual specificity) 